DC
REGN icon

Deere & Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Deere & Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,028
Closed -$1.62M – 587
2016
Q3 		$1.62M Sell
4,028
-1,018
-20% -$408K 0.09% 230
2016
Q2 		$1.76M Sell
5,046
-1,016
-17% -$391K 0.09% 193
2016
Q1 		$2.19M Sell
6,062
-2,331
-28% -$961K 0.12% 175
2015
Q4 		$4.56M Sell
8,393
-90
-1% -$48.8K 0.27% 81
2015
Q3 		$3.95M Sell
8,483
-869
-9% -$467K 0.25% 85
2015
Q2 		$4.77M Buy
9,352
+8,905
+1,992% +$4.35M 0.26% 84
2015
Q1 		$202K Sell
447
-5,305
-92% -$2.25M 0.01% 897
2014
Q4 		$2.36M Sell
5,752
-75
-1% -$29.5K 0.13% 171
2014
Q3 		$2.1M Sell
5,827
-105
-2% -$35.2K 0.12% 171
2014
Q2 		$1.68M Buy
5,932
+3,102
+110% +$919K 0.09% 227
2014
Q1 		$850K Buy
+2,830
New +$872K 0.05% 421
2013
Q4 		– Sell
-696
Closed -$218K – 1055
2013
Q3 		$218K Buy
+696
New +$183K 0.01% 868

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Deere & Company's REGN Position: Q4 2016 in Review

Deere & Company sold out of Regeneron Pharmaceuticals (REGN) in Q4 2016, closing a stake of 4,028 shares — an estimated $1.62M sold.

Deere & Company first reported a position in REGN in Q3 2013 and held it in 12 quarters. The position peaked at $4.77M in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • Deere & Company reported no remaining Regeneron Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 4,028 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $1.62M.
  • Deere & Company first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 12 quarters.
  • Deere & Company's Regeneron Pharmaceuticals position peaked at $4.77M in Q2 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.